New pill could help adults with low platelet disorder
NCT ID NCT05029635
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tested an oral drug called HMPL-523 (sovleplenib) in 272 adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. Participants who had not responded well to prior treatments received either the drug or a placebo daily for 24 weeks. The study measured whether platelet counts could be raised and maintained at safe levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HMPL-523 (sovleplenib)
- What this could lead to
- If successful, this could provide a new oral treatment option for adults with chronic ITP who have not responded well to standard therapies.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. The drug may not prove significantly better than placebo, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of North China University of Technology
Tangshan, Hebei, China
-
Beijing Chaoyang Hospital of Capital Medical University
Beijing, Beijing Municipality, China
-
Blood Institute of the Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
-
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
-
Guangdong General Hospital
Guangzhou, Guangdong, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
-
Jinan Central Hospital Affilated to Sandong University
Jinan, Shandong, China
-
Jinshan Hospital Affiliated To Fudan University
Shanghai, Shanghai Municipality, China
-
Lanzhou University Second Hospital
Lanzhou, Gansu, China
-
LiaoCheng People's Hospital
Liaocheng, Shandong, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
-
People's Hospital of Peking University
Beijing, Beijing Municipality, China
-
Qinghai province people's hospital
Xining, Qinghai, China
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
-
Shanxi Provincial People's Hospital
Xi’an, Shanxi, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
-
Southern Hospital of Southern Medical University
Guangzhou, Guangdong, China
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
-
The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University
Huai'an, Nanjing Province, China
-
The First Affiliated Hospital Of GuangXi Medical University
Nanning, Guangxi, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
-
The First Affiliated hospital of USTC
Hefei, Anhui, China
-
The First Affilicated Hospital of Xinjiang Medical University
Ürümqi, The Xinjiang Uygur Autonomous Region, China
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The Second People's Hospital Of Shenzhen
Shenzhen, Guangdong, China
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
-
The second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
-
The second hospital of Shanxi Medical University
Taiyuan, Shanxi, China
-
Union Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
West China Hospital,Sichuan University
Chengdu, Sichuan, China
-
Xiangya Hospital Central South University
Changsha, Hunan, China
-
Xiangyang Central Hospital
Xiangyang, Hubei, China
-
Zhejiang Provincial Hospital of Chinese Medicine
Hangzhou, Zejiang Province, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for kids with ITP: drug combo aims to control bleeding
- New drug combo aims to boost platelet counts in immune disorder
- New combo aims to boost platelets in stubborn ITP
- New hope for ITP patients: switching drugs after failed treatment
- New shot aims to boost platelets in ITP patients
- New combo therapy aims to tame rare bleeding disorder